[EO-11] Platform Session 11：Neurometabolic Disorders 2

[EO-056] Long—term efficacy of gene therapy for AADC deficiency using AAV2—AADC vector

Karin Kojima¹，Akihiko Miyauchi¹，Takahiro Ikeda¹，Yoshie Kurokawa¹，Yoshiyuki Onuki²，Takeshi Nakajima²，Masahiro Hirai^1,5，Kazuhiro Muramatsu¹，Hitoshi Osaka¹，Shin—Ichi Muramatsu^3,4，Takanori Yamagata¹ (1. Department of Pediatrics, Jichi Medical University, Shimotsuke, Tochigi, Japan，2. Department of Neurosurgery, Jichi Medical University, Shimotsuke, Tochigi, Japan，3. Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Shimotsuke, Tochigi, Japan，4. Center for Gene and Cell therapy, The instirute of medical science, The University of Tokyo, Tokyo, Japan，5. Department of Cognitive and Psychological Sciences, Graduate School of Informatics, Nagoya University, Nagoya, Aichi, Japan)